Relacorilant, a selective glucocorticoid receptor modulator, provides sustained blood pressure control and metabolic benefits in patients with Cushing syndrome, according to a phase 3 trial.
The FDA assigned a PDUFA target action date of December 22, 2026 – – The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction in ...
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Hypertension is often described in simple terms: a chronic condition in which blood pressure remains persistently elevated. Yet behind those numbers o.
A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...
A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress—heart muscle damage without symptoms of ...
Diabetes and hypertension are silent yet powerful enemies of kidney health. A urologist says that protecting the kidneys is ...
Pulmonary hypertension is a serious condition that happens when the blood pressure in the arteries of the lungs is higher than normal. This problem puts extra stress on the heart over time, especially ...
Raised blood pressure remains the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide ...
The BPM Vision doesn't actually work with Withings' Cardio Check-Up—you need an ECG-enabled Withings tracker, like the ...
The Apple Watch is packed with powerful health and wellness features, and this one could genuinely save your life. Hypertension Notifications can notify you if your Apple Watch detects consistently ...
Medicare’s 2025 APCM billing update pays primary care physicians a monthly per-patient fee for care management; no time-tracking required. APCM is the biggest primary care billing opportunity since ...